Financial Performance - Q4 2024 system-wide sales increased by 9%, up from 8% in Q3 2024[13] - Q4 2024 comp sales increased by 6%, up from 4% in Q3 2024[13] - Q4 2024 revenue from continuing operations increased by 14%, up from 10% in Q3 2024[13] - 2024 revenue from continuing operations was $51.9 million, a 10% increase compared to $47.0 million in 2023[35] Operational Metrics - The Joint Corp treated 1.9 million unique patients in 2024, up from 1.7 million in 2023[25] - The Joint Corp had 957,000 new patients in 2024, compared to 932,000 in 2023[25] - There were 14.7 million adjustments in 2024, up from 13.6 million in 2023[25] - 36% of new patients in 2024 were new to chiropractic[25] - 85% of system-wide gross sales in 2024 were from monthly memberships, consistent with 2023[25] 2025 Guidance - The Joint Corp projects system-wide sales between $550 million and $570 million for 2025[36] - The Joint Corp anticipates mid-single-digit system-wide comp sales growth for clinics open 13 months or more in 2025[36] - The Joint Corp estimates consolidated Adjusted EBITDA between $10.0 million and $11.5 million for 2025[36]

The Joint Corp. (NASDAQ:JYNT) Q4 2024 Earnings Conference Call March 13, 2025 5:00 PM ET Company Participants Kirsten Chapman - IR, Alliance Advisors Sanjiv Razdan - President & CEO Jake Singleton - CFO Conference Call Participants Jeff Van Sinderen - B. Riley Securities Jeremy Hamblin - Craig-Hallum Capital Group George Kelly - ROTH Capital Partners Anthony Vendetti - Maxim Group Operator Good afternoon, and welcome to The Joint Corp. Fourth Quarter and Year End 2024 Financial Results Conference Call. All ...

分组1 - The Joint Corp. reported quarterly earnings of $0.06 per share, matching the Zacks Consensus Estimate, but down from $0.07 per share a year ago [1] - The company's revenues for the quarter ended December 2024 were $14.45 million, missing the Zacks Consensus Estimate by 50.09%, and significantly lower than the $30.61 million reported a year ago [2] - The stock has lost about 1% since the beginning of the year, while the S&P 500 has declined by 4.8% [3] 分组2 - The earnings outlook for The Joint is mixed, with current consensus EPS estimates at $0.02 on $27.1 million in revenues for the coming quarter and $0.53 on $95.61 million in revenues for the current fiscal year [7] - The Zacks Industry Rank for Medical - HMOs is in the bottom 29% of over 250 Zacks industries, indicating potential challenges for stock performance [8]

Financial Data and Key Metrics Changes - System wide sales increased to $530.3 million, up 9% in Q4 2024 compared to 8% in Q3 2024 [15] - Revenue for continuing operations increased 14% in Q4 2024, up from 10% in Q3 2024 [16] - Consolidated adjusted EBITDA was $3.3 million for Q4 2024 and $11.4 million for the full year 2024 [17][34] Business Line Data and Key Metrics Changes - System wide comp sales for all clinics opened for thirteen months were 6% in Q4 2024, up from 4% in Q3 2024 [15] - System wide comp sales for mature clinics opened for 48 months were modestly positive for Q4 2024, improving from negative 2% in Q3 2024 [15][26] - Revenue from franchise operations reached $14.4 million in Q4 2024, compared to $12.7 million in Q4 2023, reflecting a 14% increase [29] Market Data and Key Metrics Changes - The company served approximately 950,000 new patients in 2024, with 36% of them being new to chiropractic care [10][25] - The annual spending on chiropractic care is estimated at $20.6 billion, with out-of-pocket spending increasing from 37% to 42% [37] Company Strategy and Development Direction - The company aims to strengthen its position as a leading chiropractic care provider and become a pure play franchisor [9][12] - Plans include refranchising to reduce overhead and increase operating leverage, with a focus on dynamic revenue management and enhancing digital marketing [18][21] - The company is exploring new revenue streams, including B2B opportunities and additional clinical services [19][86] Management Comments on Operating Environment and Future Outlook - Management noted that consumer behavior is being affected by stubborn inflation and economic uncertainty, impacting patient demographics [47][48] - The company expects 2025 to be a transition year as it shifts from corporate-owned clinics to a franchise model, which will enhance profitability [35][90] - Management is focused on reducing G&A expenses to improve the bottom line significantly in the coming years [29][92] Other Important Information - The company opened 57 franchise clinics in 2024 and closed 18, resulting in a total of 967 clinics, with 87% being franchise clinics [27] - The company has received accolades, including being recognized as number 38 on the Fast and Serious 2025 list of the smartest growing franchises [44] Q&A Session Summary Question: Comments on potentially slower consumer behavior in Q1 metrics - Management acknowledged signs of consumer response to inflation and economic uncertainty, particularly affecting their target demographic [47][48] Question: Retention rates and trends - Retention rates remained stable, with strong conversion rates for new patients and slight upticks in attrition typical for January [51][53] Question: Status of refranchising efforts - The company has 125 corporate clinics, with the majority under LOI negotiations, aiming to complete refranchising in the first half of the year [55][80] Question: Trends in same store sales - Year-to-date trends are consistent with Q4 figures, with expectations for Q1 to align with previous trends [60][61] Question: Valuation of LOIs for refranchising - Management indicated that bidders are looking at a multiple of EBITDA for the corporate clinics, with ongoing negotiations [62][64] Question: Customer acquisition costs and revenue growth - Increased marketing spend is aimed at driving new patient acquisition, with a focus on optimizing customer acquisition costs [66][68] Question: Pricing strategy and legacy customer rates - The last wholesale price increase occurred in March 2022, with 80% of active members on standard rates and 20% on legacy rates [72][74] Question: Timing for new services and retail products - Exploration of new services and retail products is ongoing, with a focus on strengthening core operations before launching new initiatives [86]

Company Overview - The Joint Corp. announced operating metrics for the year ended December 31, 2024, in a press release dated January 16, 2025[4] - The company is listed on the NASDAQ Capital Market under the trading symbol JYNT[2] - The report does not indicate whether The Joint Corp. is an emerging growth company[3] Regulatory Information - The information provided in the press release is not deemed "filed" under the Securities Exchange Act of 1934[5] - The press release is furnished as Exhibit 99.1 to the Current Report on Form 8-K[4] - The report was signed by Sanjiv Razdan, President and Chief Executive Officer, on January 16, 2025[10]

- Grew revenue from continuing operations 10% annually and 14% quarterly compared to the same period in 2023 - - Increased system-wide sales 9% for both the year and Q4 2024 – SCOTTSDALE, Ariz., March 13, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), a national operator, manager, and franchisor of chiropractic clinics, reported its financial results for the quarter ended December 31, 2024. The results of operations of the corporate clinics business segment have been classified as discontinued op ...

Highly accomplished franchise development leader with over 20 years of experience to lead growth SCOTTSDALE, Ariz., March 11, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, welcomes Craig Sherwood as the company’s new Senior Vice President of Development. He will report to President and CEO Sanjiv Razdan. “Craig is a highly accomplished franchise development leader with over 25 years of experience driving s ...

Core Insights - Direct Digital Holdings, Inc. and Green Tea Technology have established a joint venture named Teranexa to enhance city operations using AI solutions [1][4] - Teranexa aims to provide a comprehensive platform that integrates hardware, software, and services to address urban challenges and improve livability [2][6] - The joint venture combines Direct Digital Holdings' expertise in data monetization with Green Tea Technology's rapid IT project deployment capabilities [3][6] Company Contributions - Direct Digital Holdings will leverage its experience in data-driven digital media strategies to support Teranexa's initiatives [7][8] - Green Tea Technology will contribute its proficiency in delivering hybrid cloud solutions and IT infrastructure [9][10] Service Offering - Teranexa will offer a Smart City as a Service AI platform designed to facilitate data-driven decision-making for municipalities [4][6] - The platform aims to streamline city operations, improve services, and create new revenue streams by transforming raw city data into actionable insights [6] Launch and Networking - Teranexa will be introduced during a soft launch event at SXSW on March 7, 2025, in Austin, Texas, providing an opportunity for industry professionals to learn about its innovative approach [4][5]

SCOTTSDALE, Ariz., March 03, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest provider of chiropractic care through The Joint Chiropractic® network, announced that management is scheduled to attend the 37th Annual Roth Conference on March 16th-18th. The conference is being held at The Laguna Cliffs Marriott in Dana Point, CA. President and Chief Executive Officer Sanjiv Razdan and Chief Financial Officer Jake Singleton will host one-on-one meetings on March 17th and 18th. Intere ...

Group 1 - Crescent Energy (NYSE: CRGY) announced its fourth quarter and annual earnings, highlighting a joint venture in the Uinta Basin and significant growth in cash flow [2] - The management of Crescent Energy emphasizes the cyclical nature of the oil and gas industry, which requires patience and experience for successful investment [2] Group 2 - The analysis of oil and gas companies, including Crescent Energy, focuses on identifying undervalued firms by examining their balance sheets, competitive positions, and development prospects [1]